drugset / Trial / NCT02419417
Study of BMS-986158 in Subjects With Select Advanced Cancers
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the safety, tolerability, pharmacokinetics, and pharmacodynamics of BMS-986158 in subjects with select advanced cancers
Timeline
- Start
- 2015-06-19
- Primary completion
- 2021-03-17
- Completion
- 2021-03-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EZOBRESIB | Small molecule | — | — |
| Subject | Nivolumab | Monoclonal antibody | — | — |